| 1 | units | 7,108 |
| 2 | units/ml | 132 |
| 3 | atmospheres | 78 |
| 4 | tabs | 28 |
| 5 | units/day | 26 |
| 6 | units/g | 12 |
| 7 | units/year | 11 |
| 8 | unit/ml | 9 |
| 9 | units/d | 6 |
| 10 | ybo3 | 6 |
| 11 | mpn/g | 5 |
| 12 | s30 | 5 |
| 13 | tataricae | 5 |
| 14 | diphenyl-1-picrylhydrazyl | 4 |
| 15 | nababo3 | 4 |
| 16 | self-explanations | 4 |
| 17 | unit-erythroid | 4 |
| 18 | units/m2 | 4 |
| 19 | alsap | 3 |
| 20 | imp-15 | 3 |
| 21 | oxonol | 3 |
| 22 | u01 | 3 |
| 23 | units/horn | 3 |
| 24 | 2'-o-ribosylribonucleosides | 2 |
| 25 | 3.75microg | 2 |
| 26 | =2.48 | 2 |
| 27 | ag-pt | 2 |
| 28 | emps/μl | 2 |
| 29 | epoxide-1 | 2 |
| 30 | group-common | 2 |
| 31 | ln3m5o12 | 2 |
| 32 | prescription/dosing | 2 |
| 33 | putas | 2 |
| 34 | smartseries | 2 |
| 35 | tetrachlorocatechol | 2 |
| 36 | units/eye | 2 |
| 37 | units/strain/d | 2 |
| 38 | +/-.38 | 1 |
| 39 | +/-.42 | 1 |
| 40 | +/-57 | 1 |
| 41 | +2s.d | 1 |
| 42 | -5.667 | 1 |
| 43 | -a-a-a- | 1 |
| 44 | -a-b-a | 1 |
| 45 | 0.89kcalg | 1 |
| 46 | 1.10789 | 1 |
| 47 | 10.0μg/ml | 1 |
| 48 | 11,309 | 1 |
| 49 | 15,100 | 1 |
| 50 | 1™ | 1 |
| 51 | 2.03-2.04 | 1 |
| 52 | 24/238 | 1 |
| 53 | 28.87s | 1 |
| 54 | 29/238 | 1 |
| 55 | 4-phenylsemicarbazone | 1 |
| 56 | 48±25 | 1 |
| 57 | 5.4±6.0 | 1 |
| 58 | 57396 | 1 |
| 59 | 61:577-584 | 1 |
| 60 | 63370 | 1 |
| 61 | 7-hydroxy-2-oxo-6- | 1 |
| 62 | 71:1351-1362 | 1 |
| 63 | 83.5+/-7.8 | 1 |
| 64 | 8304 | 1 |
| 65 | access-induced | 1 |
| 66 | acid,10-o-aminoanilide | 1 |
| 67 | acid-1'-oate | 1 |
| 68 | acid-28-o-beta-d-glucopyranoside | 1 |
| 69 | acid-κ | 1 |
| 70 | agglutination/immobilization | 1 |
| 71 | al-sehha | 1 |
| 72 | arylnickel | 1 |
| 73 | assay- | 1 |
| 74 | assay.the | 1 |
| 75 | as≥2 | 1 |
| 76 | autohemolysis | 1 |
| 77 | av-interval | 1 |
| 78 | b-2413 | 1 |
| 79 | b-2474 | 1 |
| 80 | b-2539 | 1 |
| 81 | b-2669 | 1 |
| 82 | b-2745 | 1 |
| 83 | back-averaging | 1 |
| 84 | beta-1-globulin | 1 |
| 85 | beta-tubulin-ss-fluorobenzyl | 1 |
| 86 | biarylmannosides | 1 |
| 87 | bold-imaging | 1 |
| 88 | carbapanemase | 1 |
| 89 | casein-casein | 1 |
| 90 | chemotherapy+bevacizumab | 1 |
| 91 | cmy-4 | 1 |
| 92 | cost/gain | 1 |
| 93 | criteria/cut-offs | 1 |
| 94 | diagnosis.intervention | 1 |
| 95 | diet.twenty-three | 1 |
| 96 | discomfort/distress | 1 |
| 97 | emetine-type | 1 |
| 98 | epoxide-2 | 1 |
| 99 | ethoxy-3β- | 1 |
| 100 | ettringite | 1 |
| 101 | fights/arguments | 1 |
| 102 | geotemperature | 1 |
| 103 | guanosin-monophosphate | 1 |
| 104 | hexa-aqua-zinc | 1 |
| 105 | hexapeptides | 1 |
| 106 | high-repetition-rate | 1 |
| 107 | hsiaokang | 1 |
| 108 | hydronephroureters | 1 |
| 109 | hyperpolymenorrhea | 1 |
| 110 | hypogammaglobulinemias | 1 |
| 111 | hystology | 1 |
| 112 | ich-1/ced | 1 |
| 113 | in-plain | 1 |
| 114 | ineractions | 1 |
| 115 | listerosis | 1 |
| 116 | loxodrome | 1 |
| 117 | lymphoablation | 1 |
| 118 | matuszewski | 1 |
| 119 | methylselenol | 1 |
| 120 | mg-ldhs | 1 |
| 121 | milligram-amounts | 1 |
| 122 | ml/dish | 1 |
| 123 | mm-17±4.8 | 1 |
| 124 | mm-8±4.5 | 1 |
| 125 | mono-o-dimethyltrifluoropropylsilyl | 1 |
| 126 | n2-o2 | 1 |
| 127 | nali2po4 | 1 |
| 128 | nano-coating | 1 |
| 129 | network-daily | 1 |
| 130 | nitrato/perchlorato | 1 |
| 131 | non-lethally | 1 |
| 132 | o-4'-neolignan | 1 |
| 133 | o-acid | 1 |
| 134 | o-beta-d-glucopyranosyl- | 1 |
| 135 | o-bis-β-d-glucopyranosyl- | 1 |
| 136 | oleylphosphocholine | 1 |
| 137 | peg-gna-nisvs | 1 |
| 138 | pg-teq | 1 |
| 139 | phenylproply | 1 |
| 140 | phosphatidylinositol-specific | 1 |
| 141 | photoallergies | 1 |
| 142 | photoimmunotherapy | 1 |
| 143 | plasminogen-rich | 1 |
| 144 | poly-n-acetyl-d-glucosamine | 1 |
| 145 | polyketal | 1 |
| 146 | protein-8 | 1 |
| 147 | protein-balanced | 1 |
| 148 | provider/cardiologist | 1 |
| 149 | pyridyl-triazole | 1 |
| 150 | reduced-/b/ | 1 |
| 151 | scale=0.21 | 1 |
| 152 | scale=4 | 1 |
| 153 | scfi | 1 |
| 154 | sd±8.101 | 1 |
| 155 | significantrepeated | 1 |
| 156 | size-complementary | 1 |
| 157 | slab-like | 1 |
| 158 | solution-ffs | 1 |
| 159 | source-tweet | 1 |
| 160 | stress/na | 1 |
| 161 | tatricae | 1 |
| 162 | telangiectasia-rad3-related | 1 |
| 163 | thiazolidine-4-carboselenoate | 1 |
| 164 | trans-m | 1 |
| 165 | treatment-plans | 1 |
| 166 | trials/meta-analysis | 1 |
| 167 | triflate-complexes | 1 |
| 168 | ulk1-dependent | 1 |
| 169 | unit-per-gram | 1 |
| 170 | unit-spleen | 1 |
| 171 | unit.a | 1 |
| 172 | units/animal | 1 |
| 173 | units/broiler | 1 |
| 174 | units/die | 1 |
| 175 | units/dose | 1 |
| 176 | units/pig | 1 |
| 177 | vet™ | 1 |
| 178 | weight-placement | 1 |
| 179 | work/100 | 1 |
| 180 | yf3 | 1 |
| 181 | zrf | 1 |
| 182 | φc31 | 1 |
| 1 | +/-.38 | 1 |
| 2 | +/-.42 | 1 |
| 3 | +/-57 | 1 |
| 4 | +2s.d | 1 |
| 5 | -5.667 | 1 |
| 6 | -a-a-a- | 1 |
| 7 | -a-b-a | 1 |
| 8 | 0.89kcalg | 1 |
| 9 | 1.10789 | 1 |
| 10 | 10.0μg/ml | 1 |
| 11 | 11,309 | 1 |
| 12 | 15,100 | 1 |
| 13 | 1™ | 1 |
| 14 | 2'-o-ribosylribonucleosides | 2 |
| 15 | 2.03-2.04 | 1 |
| 16 | 24/238 | 1 |
| 17 | 28.87s | 1 |
| 18 | 29/238 | 1 |
| 19 | 3.75microg | 2 |
| 20 | 4-phenylsemicarbazone | 1 |
| 21 | 48±25 | 1 |
| 22 | 5.4±6.0 | 1 |
| 23 | 57396 | 1 |
| 24 | 61:577-584 | 1 |
| 25 | 63370 | 1 |
| 26 | 7-hydroxy-2-oxo-6- | 1 |
| 27 | 71:1351-1362 | 1 |
| 28 | 83.5+/-7.8 | 1 |
| 29 | 8304 | 1 |
| 30 | =2.48 | 2 |
| 31 | access-induced | 1 |
| 32 | acid,10-o-aminoanilide | 1 |
| 33 | acid-1'-oate | 1 |
| 34 | acid-28-o-beta-d-glucopyranoside | 1 |
| 35 | acid-κ | 1 |
| 36 | ag-pt | 2 |
| 37 | agglutination/immobilization | 1 |
| 38 | al-sehha | 1 |
| 39 | alsap | 3 |
| 40 | arylnickel | 1 |
| 41 | assay- | 1 |
| 42 | assay.the | 1 |
| 43 | as≥2 | 1 |
| 44 | atmospheres | 78 |
| 45 | autohemolysis | 1 |
| 46 | av-interval | 1 |
| 47 | b-2413 | 1 |
| 48 | b-2474 | 1 |
| 49 | b-2539 | 1 |
| 50 | b-2669 | 1 |
| 51 | b-2745 | 1 |
| 52 | back-averaging | 1 |
| 53 | beta-1-globulin | 1 |
| 54 | beta-tubulin-ss-fluorobenzyl | 1 |
| 55 | biarylmannosides | 1 |
| 56 | bold-imaging | 1 |
| 57 | carbapanemase | 1 |
| 58 | casein-casein | 1 |
| 59 | chemotherapy+bevacizumab | 1 |
| 60 | cmy-4 | 1 |
| 61 | cost/gain | 1 |
| 62 | criteria/cut-offs | 1 |
| 63 | diagnosis.intervention | 1 |
| 64 | diet.twenty-three | 1 |
| 65 | diphenyl-1-picrylhydrazyl | 4 |
| 66 | discomfort/distress | 1 |
| 67 | emetine-type | 1 |
| 68 | emps/μl | 2 |
| 69 | epoxide-1 | 2 |
| 70 | epoxide-2 | 1 |
| 71 | ethoxy-3β- | 1 |
| 72 | ettringite | 1 |
| 73 | fights/arguments | 1 |
| 74 | geotemperature | 1 |
| 75 | group-common | 2 |
| 76 | guanosin-monophosphate | 1 |
| 77 | hexa-aqua-zinc | 1 |
| 78 | hexapeptides | 1 |
| 79 | high-repetition-rate | 1 |
| 80 | hsiaokang | 1 |
| 81 | hydronephroureters | 1 |
| 82 | hyperpolymenorrhea | 1 |
| 83 | hypogammaglobulinemias | 1 |
| 84 | hystology | 1 |
| 85 | ich-1/ced | 1 |
| 86 | imp-15 | 3 |
| 87 | in-plain | 1 |
| 88 | ineractions | 1 |
| 89 | listerosis | 1 |
| 90 | ln3m5o12 | 2 |
| 91 | loxodrome | 1 |
| 92 | lymphoablation | 1 |
| 93 | matuszewski | 1 |
| 94 | methylselenol | 1 |
| 95 | mg-ldhs | 1 |
| 96 | milligram-amounts | 1 |
| 97 | ml/dish | 1 |
| 98 | mm-17±4.8 | 1 |
| 99 | mm-8±4.5 | 1 |
| 100 | mono-o-dimethyltrifluoropropylsilyl | 1 |
| 101 | mpn/g | 5 |
| 102 | n2-o2 | 1 |
| 103 | nababo3 | 4 |
| 104 | nali2po4 | 1 |
| 105 | nano-coating | 1 |
| 106 | network-daily | 1 |
| 107 | nitrato/perchlorato | 1 |
| 108 | non-lethally | 1 |
| 109 | o-4'-neolignan | 1 |
| 110 | o-acid | 1 |
| 111 | o-beta-d-glucopyranosyl- | 1 |
| 112 | o-bis-β-d-glucopyranosyl- | 1 |
| 113 | oleylphosphocholine | 1 |
| 114 | oxonol | 3 |
| 115 | peg-gna-nisvs | 1 |
| 116 | pg-teq | 1 |
| 117 | phenylproply | 1 |
| 118 | phosphatidylinositol-specific | 1 |
| 119 | photoallergies | 1 |
| 120 | photoimmunotherapy | 1 |
| 121 | plasminogen-rich | 1 |
| 122 | poly-n-acetyl-d-glucosamine | 1 |
| 123 | polyketal | 1 |
| 124 | prescription/dosing | 2 |
| 125 | protein-8 | 1 |
| 126 | protein-balanced | 1 |
| 127 | provider/cardiologist | 1 |
| 128 | putas | 2 |
| 129 | pyridyl-triazole | 1 |
| 130 | reduced-/b/ | 1 |
| 131 | s30 | 5 |
| 132 | scale=0.21 | 1 |
| 133 | scale=4 | 1 |
| 134 | scfi | 1 |
| 135 | sd±8.101 | 1 |
| 136 | self-explanations | 4 |
| 137 | significantrepeated | 1 |
| 138 | size-complementary | 1 |
| 139 | slab-like | 1 |
| 140 | smartseries | 2 |
| 141 | solution-ffs | 1 |
| 142 | source-tweet | 1 |
| 143 | stress/na | 1 |
| 144 | tabs | 28 |
| 145 | tataricae | 5 |
| 146 | tatricae | 1 |
| 147 | telangiectasia-rad3-related | 1 |
| 148 | tetrachlorocatechol | 2 |
| 149 | thiazolidine-4-carboselenoate | 1 |
| 150 | trans-m | 1 |
| 151 | treatment-plans | 1 |
| 152 | trials/meta-analysis | 1 |
| 153 | triflate-complexes | 1 |
| 154 | u01 | 3 |
| 155 | ulk1-dependent | 1 |
| 156 | unit-erythroid | 4 |
| 157 | unit-per-gram | 1 |
| 158 | unit-spleen | 1 |
| 159 | unit.a | 1 |
| 160 | unit/ml | 9 |
| 161 | units | 7,108 |
| 162 | units/animal | 1 |
| 163 | units/broiler | 1 |
| 164 | units/d | 6 |
| 165 | units/day | 26 |
| 166 | units/die | 1 |
| 167 | units/dose | 1 |
| 168 | units/eye | 2 |
| 169 | units/g | 12 |
| 170 | units/horn | 3 |
| 171 | units/m2 | 4 |
| 172 | units/ml | 132 |
| 173 | units/pig | 1 |
| 174 | units/strain/d | 2 |
| 175 | units/year | 11 |
| 176 | vet™ | 1 |
| 177 | weight-placement | 1 |
| 178 | work/100 | 1 |
| 179 | ybo3 | 6 |
| 180 | yf3 | 1 |
| 181 | zrf | 1 |
| 182 | φc31 | 1 |
| 1 | 7-hydroxy-2-oxo-6- | 1 |
| 2 | -a-a-a- | 1 |
| 3 | o-beta-d-glucopyranosyl- | 1 |
| 4 | o-bis-β-d-glucopyranosyl- | 1 |
| 5 | assay- | 1 |
| 6 | ethoxy-3β- | 1 |
| 7 | reduced-/b/ | 1 |
| 8 | 5.4±6.0 | 1 |
| 9 | 15,100 | 1 |
| 10 | work/100 | 1 |
| 11 | s30 | 5 |
| 12 | 63370 | 1 |
| 13 | epoxide-1 | 2 |
| 14 | sd±8.101 | 1 |
| 15 | u01 | 3 |
| 16 | scale=0.21 | 1 |
| 17 | φc31 | 1 |
| 18 | epoxide-2 | 1 |
| 19 | ln3m5o12 | 2 |
| 20 | +/-.42 | 1 |
| 21 | 71:1351-1362 | 1 |
| 22 | units/m2 | 4 |
| 23 | n2-o2 | 1 |
| 24 | as≥2 | 1 |
| 25 | b-2413 | 1 |
| 26 | yf3 | 1 |
| 27 | nababo3 | 4 |
| 28 | ybo3 | 6 |
| 29 | cmy-4 | 1 |
| 30 | 2.03-2.04 | 1 |
| 31 | 8304 | 1 |
| 32 | b-2474 | 1 |
| 33 | 61:577-584 | 1 |
| 34 | scale=4 | 1 |
| 35 | nali2po4 | 1 |
| 36 | mm-8±4.5 | 1 |
| 37 | imp-15 | 3 |
| 38 | 48±25 | 1 |
| 39 | b-2745 | 1 |
| 40 | 57396 | 1 |
| 41 | +/-57 | 1 |
| 42 | -5.667 | 1 |
| 43 | protein-8 | 1 |
| 44 | mm-17±4.8 | 1 |
| 45 | 83.5+/-7.8 | 1 |
| 46 | +/-.38 | 1 |
| 47 | 24/238 | 1 |
| 48 | 29/238 | 1 |
| 49 | =2.48 | 2 |
| 50 | 11,309 | 1 |
| 51 | b-2539 | 1 |
| 52 | b-2669 | 1 |
| 53 | 1.10789 | 1 |
| 54 | -a-b-a | 1 |
| 55 | unit.a | 1 |
| 56 | hyperpolymenorrhea | 1 |
| 57 | al-sehha | 1 |
| 58 | stress/na | 1 |
| 59 | chemotherapy+bevacizumab | 1 |
| 60 | phosphatidylinositol-specific | 1 |
| 61 | hexa-aqua-zinc | 1 |
| 62 | +2s.d | 1 |
| 63 | units/strain/d | 2 |
| 64 | units/d | 6 |
| 65 | ich-1/ced | 1 |
| 66 | protein-balanced | 1 |
| 67 | access-induced | 1 |
| 68 | significantrepeated | 1 |
| 69 | telangiectasia-rad3-related | 1 |
| 70 | o-acid | 1 |
| 71 | unit-erythroid | 4 |
| 72 | tataricae | 5 |
| 73 | tatricae | 1 |
| 74 | acid,10-o-aminoanilide | 1 |
| 75 | acid-28-o-beta-d-glucopyranoside | 1 |
| 76 | diet.twenty-three | 1 |
| 77 | assay.the | 1 |
| 78 | units/die | 1 |
| 79 | slab-like | 1 |
| 80 | pyridyl-triazole | 1 |
| 81 | loxodrome | 1 |
| 82 | oleylphosphocholine | 1 |
| 83 | poly-n-acetyl-d-glucosamine | 1 |
| 84 | 4-phenylsemicarbazone | 1 |
| 85 | emetine-type | 1 |
| 86 | geotemperature | 1 |
| 87 | carbapanemase | 1 |
| 88 | units/dose | 1 |
| 89 | guanosin-monophosphate | 1 |
| 90 | acid-1'-oate | 1 |
| 91 | thiazolidine-4-carboselenoate | 1 |
| 92 | high-repetition-rate | 1 |
| 93 | ettringite | 1 |
| 94 | units/eye | 2 |
| 95 | zrf | 1 |
| 96 | mpn/g | 5 |
| 97 | units/g | 12 |
| 98 | units/pig | 1 |
| 99 | 0.89kcalg | 1 |
| 100 | hsiaokang | 1 |
| 101 | bold-imaging | 1 |
| 102 | back-averaging | 1 |
| 103 | prescription/dosing | 2 |
| 104 | nano-coating | 1 |
| 105 | 3.75microg | 2 |
| 106 | plasminogen-rich | 1 |
| 107 | ml/dish | 1 |
| 108 | scfi | 1 |
| 109 | matuszewski | 1 |
| 110 | units/animal | 1 |
| 111 | polyketal | 1 |
| 112 | av-interval | 1 |
| 113 | arylnickel | 1 |
| 114 | 10.0μg/ml | 1 |
| 115 | units/ml | 132 |
| 116 | unit/ml | 9 |
| 117 | tetrachlorocatechol | 2 |
| 118 | methylselenol | 1 |
| 119 | oxonol | 3 |
| 120 | mono-o-dimethyltrifluoropropylsilyl | 1 |
| 121 | diphenyl-1-picrylhydrazyl | 4 |
| 122 | beta-tubulin-ss-fluorobenzyl | 1 |
| 123 | emps/μl | 2 |
| 124 | trans-m | 1 |
| 125 | unit-per-gram | 1 |
| 126 | o-4'-neolignan | 1 |
| 127 | unit-spleen | 1 |
| 128 | cost/gain | 1 |
| 129 | in-plain | 1 |
| 130 | casein-casein | 1 |
| 131 | beta-1-globulin | 1 |
| 132 | lymphoablation | 1 |
| 133 | agglutination/immobilization | 1 |
| 134 | diagnosis.intervention | 1 |
| 135 | group-common | 2 |
| 136 | units/horn | 3 |
| 137 | nitrato/perchlorato | 1 |
| 138 | alsap | 3 |
| 139 | pg-teq | 1 |
| 140 | units/year | 11 |
| 141 | units/broiler | 1 |
| 142 | 28.87s | 1 |
| 143 | hypogammaglobulinemias | 1 |
| 144 | putas | 2 |
| 145 | tabs | 28 |
| 146 | 2'-o-ribosylribonucleosides | 2 |
| 147 | biarylmannosides | 1 |
| 148 | hexapeptides | 1 |
| 149 | photoallergies | 1 |
| 150 | smartseries | 2 |
| 151 | atmospheres | 78 |
| 152 | triflate-complexes | 1 |
| 153 | solution-ffs | 1 |
| 154 | criteria/cut-offs | 1 |
| 155 | mg-ldhs | 1 |
| 156 | listerosis | 1 |
| 157 | trials/meta-analysis | 1 |
| 158 | autohemolysis | 1 |
| 159 | treatment-plans | 1 |
| 160 | self-explanations | 4 |
| 161 | ineractions | 1 |
| 162 | hydronephroureters | 1 |
| 163 | discomfort/distress | 1 |
| 164 | units | 7,108 |
| 165 | fights/arguments | 1 |
| 166 | milligram-amounts | 1 |
| 167 | peg-gna-nisvs | 1 |
| 168 | source-tweet | 1 |
| 169 | ulk1-dependent | 1 |
| 170 | weight-placement | 1 |
| 171 | ag-pt | 2 |
| 172 | provider/cardiologist | 1 |
| 173 | units/day | 26 |
| 174 | hystology | 1 |
| 175 | network-daily | 1 |
| 176 | non-lethally | 1 |
| 177 | phenylproply | 1 |
| 178 | photoimmunotherapy | 1 |
| 179 | size-complementary | 1 |
| 180 | 1™ | 1 |
| 181 | vet™ | 1 |
| 182 | acid-κ | 1 |